In individuals with Alzheimer’s disease, acetylcholinesterase exhibits a higher prevalence than butyrylcholinesterase within cerebral tissues, playing a pivotal role in the degradation of acetylcholine in the cerebral cortex and hippocampus. The gene discussed is BCHE; the disease is Alzheimer disease.